BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SRD Pharmaceuticals Acquires Drug Patents For New Treatment Of AIDS; Will Apply To Utilize FDA's "Fast Track" System To Expedite Marketing Approval


10/19/2005 5:11:10 PM

SRD Pharmaceuticals, Inc. today announced it has acquired 4 U.S. patents, 16 corresponding foreign patents and 4 additional patents pending from Nissin Foods, Ltd. of Japan. The acquisition includes the associated technologies and FDA filings related to an AIDS drug developed by Nissin's Molecular Biology Institute. Nissin spent 10 years and 17 million dollars to create this drug for the treatment of AIDS, based on "humanized" monoclonal antibody (MAb) technology. The drug binds to the HIV virus and leads to the activation of a part of the immune system that disrupts the virus.

Read at BioSpace.com

   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES